Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Dianthus Therapeutics, Inc. Dianthus Therapeutics to Participate in the Jefferies Global Healthcare Conference May 30, 2024 From Dianthus Therapeutics, Inc. Via GlobeNewswire Tickers DNTH Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial Results May 09, 2024 From Dianthus Therapeutics, Inc. Via GlobeNewswire Tickers DNTH Dianthus Therapeutics to Participate in the Bank of America Securities 2024 Health Care Conference May 08, 2024 From Dianthus Therapeutics, Inc. Via GlobeNewswire Tickers DNTH Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 03, 2024 From Dianthus Therapeutics, Inc. Via GlobeNewswire Tickers DNTH Dianthus Therapeutics Announces Oral Presentation for DNTH103 at the 2024 American Academy of Neurology (AAN) Annual Meeting April 11, 2024 From Dianthus Therapeutics, Inc. Via GlobeNewswire Tickers DNTH Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 05, 2024 From Dianthus Therapeutics, Inc. Via GlobeNewswire Tickers DNTH Dianthus Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) March 07, 2024 From Dianthus Therapeutics, Inc. Via GlobeNewswire Tickers DNTH Dianthus Therapeutics Announces Initiation of Phase 2 MaGic Trial of DNTH103 In Generalized Myasthenia Gravis (gMG) February 26, 2024 From Dianthus Therapeutics, Inc. Via GlobeNewswire Tickers DNTH Dianthus Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference February 23, 2024 From Dianthus Therapeutics, Inc. Via GlobeNewswire Dianthus Therapeutics to Participate at the Guggenheim 6th Annual Biotechnology Conference January 31, 2024 From Dianthus Therapeutics, Inc. Via GlobeNewswire Dianthus Therapeutics Announces $230 Million Private Placement January 22, 2024 From Dianthus Therapeutics, Inc. Via GlobeNewswire Dianthus Therapeutics to Webcast Presentation at the 42nd Annual J.P. Morgan Healthcare Conference January 02, 2024 From Dianthus Therapeutics, Inc. Via GlobeNewswire Dianthus Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) December 04, 2023 From Dianthus Therapeutics, Inc. Via GlobeNewswire Dianthus Therapeutics Enhances Leadership Team with Appointment of Jeffrey Stavenhagen, Ph.D., as Chief Scientific Officer November 29, 2023 From Dianthus Therapeutics, Inc. Via GlobeNewswire Dianthus Therapeutics Highlights Recent Business Achievements and Third Quarter 2023 Financial Results November 09, 2023 From Dianthus Therapeutics, Inc. Via GlobeNewswire Dianthus Therapeutics to Participate in Upcoming Investor Healthcare Conferences in November November 01, 2023 From Dianthus Therapeutics, Inc. Via GlobeNewswire Dianthus Therapeutics Announces Positive Top-line Phase 1 Data and Debuts Trading on Nasdaq as DNTH September 12, 2023 From Dianthus Therapeutics, Inc. Via GlobeNewswire Magenta Therapeutics Announces Completion of Merger with Dianthus Therapeutics and Implementation of Reverse Stock Split September 11, 2023 From Dianthus Therapeutics, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.